Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-28 · accession 0000874015-24-000191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-03 | 2024-08-28+ | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $49.40 | -651 | 85.2K | -0.8% | -$32.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-29 | S | D | 331 | $49.63 | 84,823 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on April 8, 2024. |
| 2 | Common | Common Stock | 2024-08-28 | S | D | 320 | $49.16 | 85,154 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on April 8, 2024. |